Global Chinese Medicinal Materials Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Chinese Medicinal Materials market size was valued at US$ 1119 million in 2024 and is forecast to a readjusted size of USD 2381 million by 2031 with a CAGR of 11.5% during review period.

In 2023, the global pharmaceutical market will be about US$1.47 trillion, and the CAGR is expected to be about 5% in the next six years. The pharmaceutical market includes chemical drugs and biological drugs. Biologics will reach $381 billion in 2022. In contrast, the chemicals market is projected to increase from USD 1,005.6 billion in 2018 to USD 1,094 billion in 2022.

This report is a detailed and comprehensive analysis for global Chinese Medicinal Materials market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Chinese Medicinal Materials market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Chinese Medicinal Materials market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Chinese Medicinal Materials market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Chinese Medicinal Materials market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Chinese Medicinal Materials

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Chinese Medicinal Materials market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yiling Pharmaceutical, China Traditional Chinese Medicine Holdings Co., Ltd., Huisong Pharmaceuticals, Korea Ginseng Corporation, Daedong Korea Ginseng Co., Ltd., Guangzhou Pharmaceutical, Yunnan Baiyao, TASLY, Kangmei Pharmaceutical Co. Ltd, Beijing Tong Ren Tang Co. Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Chinese Medicinal Materials market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Plant-based Raw Materials

Animal Raw Materials

Mineral Raw Materials

Market segment by Application

Food Addition

Pharmaceutical

Health Products

Others

Major players covered

Yiling Pharmaceutical

China Traditional Chinese Medicine Holdings Co., Ltd.

Huisong Pharmaceuticals

Korea Ginseng Corporation

Daedong Korea Ginseng Co., Ltd.

Guangzhou Pharmaceutical

Yunnan Baiyao

TASLY

Kangmei Pharmaceutical Co. Ltd

Beijing Tong Ren Tang Co. Ltd

Henan Taloph Pharmaceutical Stock Co., Ltd

Guangdong Taiantang Pharmaceutical

BaiYunShan

Kanion Pharmaceutical

Jiangzhong Pharmaceutical

Buchang Pharma

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Chinese Medicinal Materials product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Chinese Medicinal Materials, with price, sales quantity, revenue, and global market share of Chinese Medicinal Materials from 2020 to 2025.

Chapter 3, the Chinese Medicinal Materials competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Chinese Medicinal Materials breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Chinese Medicinal Materials market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Chinese Medicinal Materials.

Chapter 14 and 15, to describe Chinese Medicinal Materials sales channel, distributors, customers, research findings and conclusion.